Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Licitra Karen A, Director. Officer active across 2 companies, notably SI-BONE, Inc.. Aggregated, 7 reports have been logged. History available since 25 June 2021. The latest transaction was disclosed on 15 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Karen A. Licitra is a Board Member at SI-BONE, Inc. and Angiodynamics Inc. She plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. Licitra is valued for her expertise in the healthcare sector.